国产无套流白浆一区二区,亚洲精品一区二区伦理,无限资源免费观看大全在线看,久久久国产综合精品,国产欧美日韩一区二区图片,精品国产91乱码一区二区三区,一区二区三区婷婷中文字幕,天天日天天干,久久久精品国产电影,国产精品免费久久久蜜桃

August 06,2024

Enitiate Bio has achieved its primary endpoint in the Phase II clinical trial of QY201 Tablets, a Class 1 innovative drug independently developed by Enitiate Bio, for the treatment of moderate-to-severe atopic dermatitis, with statistically significant and clinically meaningful results, as well as favorable safety and tolerability.

More

August 29,2023

QY201, an orally administered tablet, is a new generation JAK1/TYK2 inhibitor independently developed by E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. (hereinafter referred to as "EnitiateBio") has entered the phase II clinical trial.

More

August 18,2023

On July 26, 2023, Beijing time, E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. (hereinafter referred to as "EnitiateBio" or "Qiyuan") received the IND approval for QY201 from the FDA. This is the first clinical approval obtained by EnitiateBio from the FDA and the first U.S. IND application that was fulfilled by EnitiateBio on its own, marking the official launch of the overseas expansion plan of EnitiateBio QY201.

More

June 07,2023

On June 2, the inaugural meeting of thePharma-Derma-Alliance (PhDA) and the first Dermatology New Drug Clinical Research Summit Forum were held in Beijing; the alliance aims to strengthen synergistic innovation and scientific innovation in dermatology clinical research, new drug development and results transformation, and promote the linkage of "government, industry, academia, research and medicine", so as to promote the high-quality development and globalization of the dermatology innovative drug industry. The Alliance aims to promote the development and globalization of the dermatology innovative drug industry to benefit dermatology patients in China and around the world.

More

May 12,2023

On October 30, 2022, the company's Chairman and Chief Scientist, Dr. Wang Shen, Chief Executive Officer, Mr.Kevin Ding, and Chief Medical Officer, Mr. Jun Shi , were interviewed by Zhejiang Jing TV's "Creators World" to exchange and share their experiences around the company's development, the prospect of the pharmaceutical industry, and innovation and entrepreneurship.

More